In human breast cancer, CAFs recruited monocytes via MCP1, CXCL12, CCL2, and CCL16, leading to their differentiation into M2-like macrophages that exert immunosuppressive effects through the PD-1 axis. This evidence concerns the gene CCL2 and breast cancer.